Member Info for MrMerlot

Creating lasting value since 1997

Braveheart Investment Group plc makes strategic investments in companies we judge will outperform. The group was formed in 1997 and since 2007 has been quoted on the Alternative Investment Market of the London Stock Exchange as ‘BRH.L’.

Along with financial investment we also provide expert advice to the companies we back and help them make decisions around operations, strategy and risk. Our aim is to return cash to our shareholders while increasing the value of their shares.

I’m still waiting ! ;)

Just popped in for a look, 1 year on nothings changed ,people getting angry , arguing and losing money , glad I moved on

Pharm2farm changed their financial reporting period to run from 31 Dec 2020 to 31 Dec 2021 , will be interesting to see the figures which should show sales of masks & fertilisers etc and include credit for the mask machine unless they get hidden by smoke and mirrors

Always seemed strange to me that Volz have ( since their association with P2F) manufactured FFP2 but never seemed interested in licensing, using or developing the mask in conjunction with P2F nano material - would be interesting to know why

Braveheart Investment Group /
Our aim is to return cash to our shareholders while increasing the value of their shares. :) it hasn’t worked for me !

Mattluc - no need to torture ourselves as that is the one sure thing that the BOD can do ! :)

I still wonder why Volz never took up the option to incorporate the a-vision layer into their own masks for which they already supply to medical facilities in Germany and Czech Republic as well as AJ Dralle in the USA perhaps they could not see any added value , which seems surprising .
16 November 2020

Remote Monitored Systems plc ("RMS" or the "Company")

Pharm 2 Farm Update

The Company is pleased to issue the following update on its wholly owned subsidiary Pharm 2Farm Limited ("P2F").

P2F is continuing to receive enquiries from prospective distributors and purchasers for its viricidal mask and now anticipates that future demand for its mask may outstrip the production line capacity of five million viricidal face masks per month.

To fulfil part of the anticipated excess demand, P2F expects to supply its patented filter material, initially, to certain partner mask manufacturers, until P2F has itself procured additional production lines.

Over the weekend P2F signed binding heads of terms with a manufacturer of surgical masks in Germany. The German manufacturer will subcontract to supply complete masks to P2F to the P2F specification and brand name, and also purchase P2F filter material for their own brand masks. Under the heads of terms the manufacturer will also develop and supply anti-viral C-Fold masks using P2F filter material to extend P2F's market reach. The heads of terms are subject to final contractual agreement between the parties.

Nice to see that P2F website is finally being updated and is under reconstruction
https://www.pharm2farm.org/

Sorry passiton - trying to be helpful and it didn’t work - easiest way was to go to directors talk . net ( minus the spaces) and search baron oil

https://*************.net/baron-oil-in-a-strong-position-to-deliver-material-value-interview

Maidit - reading the RNSs don’t think they’ll actually be selling all of the first shipment - think it’s a bit of a loss leader to gauge if there is a demand as P2F will be ploughing part of the initial profits back into promotion and supporting VKE.

“These masks will, in part, be distributed to interested parties in India, with whom VKE have been in discussions, to help establish the level of demand and timeframes for future orders.”

“ VKE has placed an initial order for 350,000 Pro-Larva masks to be airfreighted direct to their distribution centre in India. The masks will be distributed via well-established retail and commercial medical networks. Part of the proceeds from this order will be invested by P2F into a marketing campaign within India to support VKE and build demand for the Pro-Larva mask, which is expected to then lead to increasing repeat orders.”

Chrispy - they haven’t made 35 yet !

Following the recent launch of the product in India, the Company is looking to make delivery of 250,000 masks in the next few weeks, with the remainder of the initial order to follow.

24 June RNS
VKE has placed an initial order for 350,000 Pro-Larva masks to be airfreighted direct to their distribution centre in India. The masks will be distributed via well-established retail and commercial medical networks. Part of the proceeds from this order will be invested by P2F into a marketing campaign within India to support VKE and build demand for the Pro-Larva mask, which is expected to then lead to increasing repeat orders.

For anyone interested NNN now showing on investing.com live price feed

SS - stop the merry-go-round, I want to get off ! :) I believe the Midlothian depot rented out to a fabrication company and the Northampton for storage

RE: Volz10 Feb 2021 16:00
If you want to make 2+ 2 = whatever you want -
Check out Volz UK Ltd filing on companies house looks like they’ve taken on 2 new facilities in Northampton and Midlothian

Marab - done well ? Not by the look of my share account balance :)

https://www.londonstockexchange.com/stock/NNN/nanosynth-group-plc/company-page

Regulator - from RNS
The Company is pleased to announce the signing of a distribution agreement between the Company's wholly owned subsidiary, Pharm 2 Farm Ltd ("P2F"), and Vivek Kohli Enterprises OPC Private Ltd ("VKE") for VKE to distribute P2F's anti-viral mask, under the Pro-Larva brand name.

I think you’ll find there is just the one

See Stag International / Stag.Global

It’s a start but not big bucks yet 350k masks with some of P2F profit to be used in marketing in India - not sure how much P2F paying Volz UK to make the masks so I guess it’s probably a loss leader at the moment , let’s hope it sells well !
From RNS
VKE has placed an initial order for 350,000 Pro-Larva masks to be airfreighted direct to their distribution centre in India. The masks will be distributed via well-established retail and commercial medical networks. Part of the proceeds from this order will be invested by P2F into a marketing campaign within India to support VKE and build demand for the Pro-Larva mask, which is expected to then lead to increasing repeat orders.

Sharebel - if there was any added value to be had by using the material in masks Volz would have snapped it up in November they already had the machinery and the market to sell in to and they chose not to - I ignored this fact and got caught up in the hype when I should have sold and moved on - I guess I’m not the only one - anyway an expensive lesson learnt